Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2950-2967
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Glutamatergic dysfunction in Schizophrenia
Andreas O. Kruse, Juan Bustillo
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment
Andrea de Bartolomeis, Giuseppe De Simone, Michele De Prisco, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2811-2825
Open Access | Times Cited: 23
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Andrea de Bartolomeis, Licia Vellucci, Mark C. Austin, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 909-909
Open Access | Times Cited: 29
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17
Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 426-426
Open Access | Times Cited: 16
Neurofunctional correlates of glutamate and GABA imbalance in psychosis: A systematic review
Uzma Zahid, Ellis Chika Onwordi, Emily Hedges, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 105010-105010
Open Access | Times Cited: 23
Progressive trajectories of schizophrenia across symptoms, genes, and the brain
Sisi Jiang, Huan Huang, Jingyu Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Aberrant heartbeat-evoked potential in schizophrenia
Akihiro Koreki, Kamiyu Ogyu, Takahiro Miyazaki, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 132, pp. 110969-110969
Closed Access | Times Cited: 4
Current Treatments for Schizophrenia
Donald Goff
Oxford University Press eBooks (2025), pp. 215-230
Closed Access
Reduced temporal variability of cortical excitation/inhibition ratio in schizophrenia
Frigyes Sámuel Rácz, Kinga Farkas, Melinda Becske, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Navigating EU Privacy Law for Enhanced Data Protection in Vaccine Supply, Distribution, and Logistics Ethical Considerations and Practical Implication
Gabriel Savioz
IGI Global eBooks (2025), pp. 255-286
Closed Access
Addressing the Digital Divide in Healthcare
Joana Beleg
IGI Global eBooks (2025), pp. 309-332
Closed Access
Innovations in Health Data Protection Ethical, Legal, and Technological Perspectives in a Global Context
David M. Almeida, Nevada Barr
IGI Global eBooks (2025), pp. 171-196
Closed Access
Sustainable and Equitable Technology Transfer for Multi-Omics
Joana Beleg
IGI Global eBooks (2025), pp. 287-308
Closed Access
Ethical Implications of Predictive Analytics in Personalized Healthcare
Darcy F. de Almeida, Joana Beleg
IGI Global eBooks (2025), pp. 57-82
Closed Access
IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access
Association of the Characteristics of Brain Magnetic Resonance Imaging with Genes Related to Disease Onset in Schizophrenia Patients
Jennifer S Lin, Bo Wang, Shaoguang Chen, et al.
SLAS TECHNOLOGY (2025), pp. 100281-100281
Open Access
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia
Kamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Schizophrenia Research (2023) Vol. 252, pp. 129-137
Open Access | Times Cited: 12
Associating Multimodal Neuroimaging Abnormalities With the Transcriptome and Neurotransmitter Signatures in Schizophrenia
Yuling Luo, Debo Dong, Huan Huang, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1554-1567
Open Access | Times Cited: 11
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis and Gut–Brain Axis Function
Predrag Sikirić, Slaven Gojković, Ivan Krezić, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 676-676
Open Access | Times Cited: 9
The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry
Robert A. Bittner, Andreas Reif, Mishal Qubad
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 327-336
Open Access | Times Cited: 9
Role of the immune-kynurenine pathway in treatment-resistant schizophrenia
Wenjin Chen, Yichang Tian, Mengzhuang Gou, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 130, pp. 110926-110926
Closed Access | Times Cited: 9
Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons
Masami Arai, Etsuko Suzuki, Satoshi Kitamura, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 11, pp. e1504232024-e1504232024
Open Access | Times Cited: 3
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4571-4592
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top